Senographe Pristina
Published February 14, 2024 · Recall initiated: December 26, 2023
Summary
FDA records medical device Class II recall Z-0862-2024, published February 14, 2024 and initiated December 26, 2023. Recalling firm: GE Medical Systems, SCS; Status: Ongoing; Reported quantity: 180 units (60 US; 120 OUS); Lot: GTIN(s): 195278022745, 195278276971, 195278628916, 195278661999, 195278665379, 840682118460, 840682142052, 840682145879. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
X-ray exposure termination audible signal on Senographe Pristina with Efficiency Suite 2 intermittently not emitted per 21CFR 1020.31(j) requirements.
What to do
FDA Mandated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- GE Medical Systems, SCS
- Distributor
- Us Nationwide-Worldwide Distribution
- Lot
- GTIN(s): 195278022745, 195278276971, 195278628916, 195278661999, 195278665379, 840682118460, 840682142052, 840682145879
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- France
Related recalls
- FDAAW Server 2.0, AW Server 3.0, AW Server 3.1, AW Server 3.2October 15, 2025
- FDAGE Healthcare Innova IGS 6, Interventional fluoroscopic x-ray systemsMay 15, 2024
- FDAGE Healthcare Allia IGS 5 Pulse, Interventional fluoroscopic x-ray systemsMay 15, 2024
- FDAGE Healthcare Interact Discovery RT, Interventional fluoroscopic x-ray systemsMay 15, 2024
- FDACardinal Health Monoject, 3 mL Purple Enteral Syringe with Enfit Connection Sterile, REF 403SEFebruary 14, 2024
- FDABrightView, gamma camera system; Model Nos.: 6-digit format 882480; 12-digit format 453560279781 453560279791February 14, 2024
Questions about this recall
Was Senographe Pristina recalled?
Yes. FDA published recall Z-0862-2024 on February 14, 2024. Reported hazard: X-ray exposure termination audible signal on Senographe Pristina with Efficiency Suite 2 intermittently not emitted per 21CFR 1020.31(j) requirements.
What should I do if I have this product?
FDA Mandated · Letter